본문 바로가기

EU · EudraLex Vol.4

EU GMP Part I, Chapter 5 5.21

Prevention of cross-contamination in production

조항 원문

The outcome of the Quality Risk Management process should be the basis for determining the extent of technical and organisational measures required to control risks for cross-contamination. These could include, but are not limited to, the following:

Technical Measures

i. Dedicated manufacturing facility (premises and equipment);

ii. Self-contained production areas having separate processing equipment and separate heating, ventilation and air-conditioning (HVAC) systems. It may also be desirable to isolate certain utilities from those used in other areas;

iii. Design of manufacturing process, premises and equipment to minimize opportunities for cross-contamination during processing, maintenance and cleaning;

iv. Use of “closed systems” for processing and material/product transfer between equipment;

v. Use of physical barrier systems, including isolators, as containment measures;

vi. Controlled removal of dust close to source of the contaminant e.g. through localised extraction;

vii. Dedication of equipment, dedication of product contact parts or dedication of selected parts which are harder to clean (e.g. filters), dedication of maintenance tools;

viii. Use of single use disposable technologies;

ix. Use of equipment designed for ease of cleaning;

x. Appropriate use of air-locks and pressure cascade to confine potential airborne contaminant within a specified area;

xi. Minimising the risk of contamination caused by recirculation or re-entry of untreated or insufficiently treated air;

xii. Use of automatic clean in place systems of validated effectiveness;

xiii. For common general wash areas, separation of equipment washing, drying and storage areas.

Organisational Measures

i. Dedicating the whole manufacturing facility or a self contained production area on a campaign basis (dedicated by separation in time) followed by a cleaning process of validated effectiveness;

ii. Keeping specific protective clothing inside areas where products with high risk of cross-contamination are processed;

iii. Cleaning verification after each product campaign should be considered as a detectability tool to support effectiveness of the Quality Risk Management approach for products deemed to present higher risk;

iv. Depending on the contamination risk, verification of cleaning of non product contact surfaces and monitoring of air within the manufacturing area and/or adjoining areas in order to demonstrate effectiveness of control measures against airborne contamination or contamination by mechanical transfer;

v. Specific measures for waste handling, contaminated rinsing water and soiled gowning;

vi. Recording of spills, accidental events or deviations from procedures;

vii. Design of cleaning processes for premises and equipment such that the cleaning processes in themselves do not present a cross-contamination risk;

viii. Design of detailed records for cleaning processes to assure completion of cleaning in accordance with approved procedures and use of cleaning status labels on equipment and manufacturing areas;

ix. Use of common general wash areas on a campaign basis;

x. Supervision of working behaviour to ensure training effectiveness and compliance with the relevant procedural controls.

본문은 원문(영어)입니다. 국문 번역은 준비 중입니다.

출처: European Commission, DG SANTE · © European Union. Reuse is authorised provided the source is acknowledged (Commission Decision 2011/833/EU on the reuse of Commission documents). · 수집일 2026-11-15

Weekly Newsletter

이런 지적, 매주 월요일 한국어로 받아보세요

FDA·EMA·식약처의 새 지적과 조치를 공식 원문 링크와 함께 보내드립니다. 사이트에 새로운 기능이 생기면 함께 안내드립니다. 구독은 언제든 한 번의 클릭으로 해지할 수 있습니다.

이번 주 소식 먼저 보기

매주 월요일 발송 · 구독 신청 시 확인 메일이 발송됩니다 · 수신거부는 모든 메일 하단에서 가능합니다.